M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 24.55 CNY -1.8% Market Closed
Market Cap: 9.8B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

Net Margin
Mabwell Shanghai Bioscience Co Ltd

-532%
Current
-4 124%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-532%
=
Net Income
-1B
/
Revenue
191.4m

Net Margin Across Competitors

Country CN
Market Cap 9.8B CNY
Net Margin
-532%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 300.2B USD
Net Margin
9%
Country US
Market Cap 158.7B USD
Net Margin
13%
Country US
Market Cap 126.8B USD
Net Margin
-5%
Country US
Market Cap 115B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.3B AUD
Net Margin
18%
Country US
Market Cap 88.3B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Mabwell Shanghai Bioscience Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-532%
=
Net Income
-1B
/
Revenue
191.4m
What is the Net Margin of Mabwell Shanghai Bioscience Co Ltd?

Based on Mabwell Shanghai Bioscience Co Ltd's most recent financial statements, the company has Net Margin of -532%.